Literature DB >> 84015

Biochemical relationship between murine immune interferon and a killer cell helper factor.

P L Simon, J J Farrar, P D Dind.   

Abstract

Concanavalin A and alloantigen-stimulated mouse spleen cells release into the supernatant at least two distinct antigen-nonspecific factors that enhance the generation of cytotoxic cells in vitro. As previously reported, analysis of the supernatant by ammonium sulfate fractionation, gel filtration, hydroxylapatite chromatography, and hydrophobic chromatographic showed one of the two killer cell helper factors (KHF) to be associated with thymocyte mitogenic factor. This report demonstrates the second KHF to be separable from thymocyte mitogenic factor but inseparable from type II (immune) interferon. In addition, this KHF exhibits the same sensitivity to exposure to pH-2 buffer as does immune interferon. The KHF activity of an unfractionated supernatant, which is greater than of either the TMF-associated or interferon-associated KHF alone, is the result of the additive activities of the two independently acting helper factors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 84015

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Therapeutic use of interleukins: experimental results.

Authors:  R D Granstein; A Tominaga; M I Greene
Journal:  Surv Immunol Res       Date:  1984

2.  Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae.

Authors:  S L James; P C Natovitz; W L Farrar; E J Leonard
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

3.  Production of immune interferon by an interleukin 2-independent murine T cell line.

Authors:  W R Benjamin; P S Steeg; J J Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  Immunoregulation by mouse T-cell clones. II. The same H-Y-specific T helper clone can provide help for the generation of cytotoxic lymphocytes and antibody-secreting cells.

Authors:  H Moll; K Eichmann; M M Simon
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

5.  A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusions.

Authors:  A Bhatia; T W Rice; D McLain; P Herzog; G T Budd; S Murthy; T J Kirby; R M Bukowski
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.

Authors:  N Kan; K Ohgaki; T Inamoto; H Kodama
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Theileriosis: cell-mediated and humoral immunity.

Authors:  A C Allison; E M Eugui
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

8.  T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.

Authors:  S Gillis; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Lymphokine regulation of macrophage-derived growth factor secretion following pulmonary injury.

Authors:  E J Kovacs; J Kelley
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

10.  Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine.

Authors:  A Turano; A Balsari; E Viani; S Landolfo; L Zanoni; F Gargiulo; A Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.